Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Debra Srebnik"'
Autor:
Sterling McPherson, Emily Leickly, Frank Angelo, Michael G. McDonell, Richard K. Ries, Jordan Skalisky, Debra Srebnik, John M. Roll
Publikováno v:
Psychiatric Rehabilitation Journal. 42:26-31
Objective This study describes the perspectives of outpatients with serious mental illness (SMI) and alcohol dependence on their participation in a contingency management (CM) intervention for alcohol use. Methods Thirty-five adults with SMI and alco
Autor:
Emily Leickly, Jordan Skalisky, John M. Roll, Debra Srebnik, Sterling McPherson, Oladunni Oluwoye, Michael G. McDonell, Richard K. Ries
Publikováno v:
Cannabis and Cannabinoid Research
Introduction: People with serious mental illness (SMI) use cannabis more than any other illicit drug. Cannabis use is associated with increased psychotic symptoms and is highly comorbid with alcohol use disorders (AUDs). Despite the national trend to
Autor:
Richard K. Ries, Frank Angelo, Michael G. McDonell, Sterling McPherson, Debra Srebnik, Jordan Skalisky, Emily Leickly, Roger Vilardaga, Jenny R. Nepom, John M. Roll
Publikováno v:
American Journal of Psychiatry. 174:370-377
The authors examined whether a contingency management intervention using the ethyl glucuronide (EtG) alcohol biomarker resulted in increased alcohol abstinence in outpatients with co-occurring serious mental illnesses. Secondary objectives were to de
Publikováno v:
Journal of Community Psychology. 44:384-390
Housing First (HF) is an effective intervention for reducing homelessness and service utilization among vulnerable adults and is most often focused on individuals experiencing chronic homelessness. This study explored the effectiveness of a single-si
Autor:
Sterling McPherson, Emily Leickly, Oladunni Oluwoye, Katherine Hirchak, John M. Roll, Debra Srebnik, Jordan Skalisky, Michael G. McDonell, Richard K. Ries
Publikováno v:
The American Journal on Addictions. 26:673-675
Background and Objectives This study investigated if pretreatment ethyl glucuronide (EtG) levels corresponding to light (100 ng/mL), heavy (500 ng/mL), and very heavy (1,000 ng/mL) drinking predicted longest duration of alcohol abstinence (LDA) and p
Autor:
Sterling McPherson, Jordan Skalisky, Oladunni Oluwoye, Debra Srebnik, Michael G. McDonell, Richard K. Ries, John M. Roll, Katherine Hirchak, Emily Leickly
Publikováno v:
International journal of mental health and addiction. 16(3)
The objective of this study was to determine whether the interaction between type of serious mental illness (SMI) and pre-treatment drinking severity, assessed by ethyl glucuronide (EtG), predicts EtG-positive urine samples submitted during treatment
Autor:
John M. Roll, Michael G. McDonell, Oladunni Oluwoye, Sterling McPherson, Emily Leickly, Richard K. Ries, Jordan Skalisky, Debra Srebnik
Publikováno v:
Substance abuse. 39(3)
Background: Adults experiencing homelessness and serious mental illnesses (SMI) are at an increased risk of poor mental health and treatment outcomes compared with stably housed adults with SMI. The additional issue of alcohol misuse further complica
Autor:
Sterling McPherson, Debra Srebnik, Frank Angelo, Michael G. McDonell, John M. Roll, Sean M. Murphy, Richard K. Ries
Publikováno v:
Drug and Alcohol Dependence. 153:293-299
Background This study examines the cost-effectiveness of contingency-management (CM) for stimulant dependence among community mental health patients with serious mental illness (SMI) Methods Economic evaluation of a 12-week randomized controlled tria
Autor:
John M. Roll, Michael G. McDonell, Sterling McPherson, Emily Leickly, Roger Vilardaga, Frank Angelo, Jessica M. Lowe, Richard K. Ries, Debra Srebnik
Publikováno v:
Alcoholism: Clinical and Experimental Research. 39:905-910
An estimated 17 million Americans suffer from alcohol use disorders (Office of Applied Studies, 2013, Grant et al., 2004) and nearly 80,000 people die from alcohol-related causes every year (CDC, 2004). Accurate assessment of alcohol use is needed to
Autor:
Roger Vilardaga, Jessica M. Lowe, Frank Angelo, Sterling McPherson, Michael G. McDonell, Richard K. Ries, Debra Srebnik, Emily Leickly, John M. Roll
Publikováno v:
The American Journal of Drug and Alcohol Abuse. 41:246-250
Immunoassay urine drug screening cups that detect use for two or more days are commonly used in addiction treatment settings. Until recently, there has been no comparable immunoassay test for alcohol use in these settings.The aim of this study was to